Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	882.79	877.23	776.67	713.82	699.45	617.47
Revenue Growth (YoY)	6.63%	12.95%	8.80%	2.05%	13.28%	3.43%
Cost of Revenue	753.73	744.07	647.92	560.04	546.7	467.03
Gross Profit	129.06	133.16	128.75	153.78	152.75	150.45
Selling, General & Admin	83.52	82.9	75.69	78.18	65.89	63.62
Operating Expenses	77.56	78.33	54.18	117.61	70.36	63.62
Operating Income	51.5	54.83	74.56	36.17	82.39	86.83
Interest Expense	-21.09	-25.32	-24.91	-19.65	-12.95	-12.55
Interest & Investment Income	-	-	-	0.05	0.33	0.35
Other Non Operating Income (Expenses)	13.34	16.3	12.5	11.08	14.84	6.69
EBT Excluding Unusual Items	43.75	45.8	62.15	27.65	84.62	81.32
Gain (Loss) on Sale of Assets	0.09	0.09	0.01	0.09	0.22	0.23
Pretax Income	43.84	45.89	62.16	27.74	84.83	81.55
Income Tax Expense	16.32	14.65	15.14	12.12	8.09	7.39
Earnings From Continuing Operations	27.52	31.23	47.02	15.62	76.75	74.16
Earnings From Discontinued Operations	-3.92	-6.63	-9.22	-	-	-
Net Income to Company	23.6	24.61	37.8	15.62	76.75	74.16
Minority Interest in Earnings	1.49	1.56	2.26	1.95	0.78	0.6
Net Income	25.09	26.17	40.06	17.57	77.52	74.76
Net Income to Common	25.09	26.17	40.06	17.57	77.52	74.76
Net Income Growth	-40.21%	-34.67%	128.04%	-77.34%	3.70%	5.79%
Shares Outstanding (Basic)	30	30	30	30	30	30
Shares Outstanding (Diluted)	30	30	30	30	30	30
EPS (Basic)	0.84	0.87	1.34	0.59	2.58	2.49
EPS (Diluted)	0.84	0.87	1.34	0.59	2.58	2.49
EPS Growth	-40.21%	-34.67%	128.04%	-77.34%	3.70%	5.79%
Free Cash Flow	224.38	281.35	-155.51	133.46	-79.49	94.34
Free Cash Flow Per Share	7.48	9.38	-5.18	4.45	-2.65	3.15
Dividend Per Share	-	-	1.000	-	0.667	1.000
Dividend Growth	-	-	-	-	-33.33%	-
Gross Margin	14.62%	15.18%	16.58%	21.54%	21.84%	24.37%
Operating Margin	5.83%	6.25%	9.60%	5.07%	11.78%	14.06%
Profit Margin	2.84%	2.98%	5.16%	2.46%	11.08%	12.11%
Free Cash Flow Margin	25.42%	32.07%	-20.02%	18.70%	-11.36%	15.28%
EBITDA	60.97	64.9	85.87	47.73	91.47	93.14
EBITDA Margin	6.91%	7.40%	11.06%	6.69%	13.08%	15.08%
D&A For EBITDA	9.47	10.07	11.31	11.56	9.08	6.31
EBIT	51.5	54.83	74.56	36.17	82.39	86.83
EBIT Margin	5.83%	6.25%	9.60%	5.07%	11.78%	14.06%
Effective Tax Rate	37.22%	31.94%	24.35%	43.70%	9.53%	9.07%
Advertising Expenses	-	0.03	0.01	0.27	0.22	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.